New use of BCG for recombinant vaccines - Test2 - elhamkhani - TriplyDB

New use of BCG for recombinant vaccines

New use of BCG for recombinant vaccines

http://www.wikidata.org/entity/Q29615313

about

Studies of a ring-cleaving dioxygenase illuminate the role of cholesterol metabolism in the pathogenesis of Mycobacterium tuberculosis Characterization of phosphofructokinase activity in Mycobacterium tuberculosis reveals that a functional glycolytic carbon flow is necessary to limit the accumulation of toxic metabolic intermediates under hypoxia Initiation of methylglucose lipopolysaccharide biosynthesis in mycobacteria Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence Identification of small RNAs in Mycobacterium tuberculosis Biosynthesis of mycobacterial arabinogalactan: identification of a novel alpha(1-->3) arabinofuranosyltransferase Sulfite reduction in mycobacteria I-TRAP: a method to identify transcriptional regulator activated promoters Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy CsoR Is Essential for Maintaining Copper Homeostasis in Mycobacterium tuberculosis Mycobacterium tuberculosis proteins involved in mycolic acid synthesis and transport localize dynamically to the old growing pole and septum Biochemical and structural studies of malate synthase from Mycobacterium tuberculosis The C-Terminal Domain of the Arabinosyltransferase Mycobacterium tuberculosis EmbC Is a Lectin-Like Carbohydrate Binding Module A highly conserved mycobacterial cholesterol catabolic pathway Mycobacterium tuberculosis RNA Polymerase-binding Protein A (RbpA) and Its Interactions with Sigma Factors Mycobacterium tuberculosis Rv3406 is a type II alkyl sulfatase capable of sulfate scavenging Directed evolution of Mycobacterium tuberculosis β-lactamase reveals gatekeeper residue that regulates antibiotic resistance and catalytic efficiency Can Inhibitor-Resistant Substitutions in the Mycobacterium tuberculosis -Lactamase BlaC Lead to Clavulanate Resistance?: a Biochemical Rationale for the Use of -Lactam- -Lactamase Inhibitor Combinations The cysteine desulfurase IscS of Mycobacterium tuberculosis is involved in iron-sulfur cluster biogenesis and oxidative stress defence Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice DNA sequence, structure and gene expression of mycobacteriophage L5: a phage system for mycobacterial genetics Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis Bioluminescence screening in vitro (Bio-Siv) assays for high-volume antimycobacterial drug discovery Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein Lsr2 in M. tuberculosis Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria Optimisation of bioluminescent reporters for use with mycobacteria Mycobacterium tuberculosis universal stress protein Rv2623 regulates bacillary growth by ATP-Binding: requirement for establishing chronic persistent infection Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes Lysine auxotrophy combined with deletion of the SecA2 gene results in a safe and highly immunogenic candidate live attenuated vaccine for tuberculosis Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy Identification of a novel gene product that promotes survival of Mycobacterium smegmatis in macrophages A β-Lactamase based reporter system for ESX dependent protein translocation in mycobacteria

P2860

Q21131582-C4CE736D-B28F-48BD-8276-B757B46FB128 Q21133686-92CA56C6-5FBD-43CA-A9FF-1C764BFD5F47 Q21562429-5E6D319F-BD23-465A-A68D-5F1150B28CAB Q24544255-044A60E7-DC7F-4740-A876-239F2584D51E Q24651584-AEE474E2-CEC0-4B5F-BD0F-7B75BEFCD81E Q24656511-56FE107C-B1DA-4A23-8412-E9CA722C8696 Q24671998-A75C25F1-C3BB-4370-9F51-5CBD3AC82305 Q24791941-8B16B6A9-26A5-4EF1-B56B-6DA7776F8D84 Q24802513-FAF51BB0-0443-4E53-B3EE-3D283B83F50C Q26798372-F5B474DB-424C-4F3D-B92B-D2FEA852333E Q27317037-417DD012-6D6D-4F10-84DC-96FD749F8625 Q27333131-C5FAA24E-7DFE-4029-86F6-AB567A7CEFC8 Q27639871-17B8DD1E-E63E-4DB8-B1B2-A15278C748F1 Q27667217-0608E2EA-636A-4E0F-8601-9776EFE35322 Q27676824-6E9BFB0A-304A-4864-8D84-B94B9EBF0799 Q27677177-6687E652-EFA1-4224-B51F-1FE9D0D37C2D Q27678602-CAF08747-ABB7-4620-B282-3ECFB71DD8DA Q27679915-0914A147-D2F2-43D1-A28B-950404252796 Q27680025-7FEF3C66-F44F-4412-B6A6-CD7FF025D69F Q27689119-47919913-9E20-45C7-922A-448EF937F1D6 Q28083377-A6F557AD-F7D9-43DF-9AF9-A034047642F6 Q28210003-097815EF-D950-4E50-8FC8-441DF8B7BC90 Q28218674-E2CAB117-B954-43E2-96A1-5585D307149D Q28267537-F93C2185-6041-4000-91A5-D53890D76A12 Q28375163-27CDA81D-6FE1-42E0-AED0-F30215B1CE9E Q28378761-65C45060-59EF-433C-85E2-C817E4451027 Q28379005-DE7337EA-80AB-47EA-9209-D4A6437C75CF Q28379432-627A688F-6726-442C-9F79-911B32298DDA Q28379488-47C2CB82-77D6-4E1D-BE5B-B078F7899E3D Q28379624-7E570E77-A85D-4957-BD1F-B9E1575B2E7D Q28469237-4FD5DD01-9FEB-4E88-9900-3A5581F30262 Q28469257-1EAB2ADC-192B-4925-9C3A-4F20339682F1 Q28471837-8E93C8BD-8058-4190-8DA0-E16679DC4727 Q28474040-CEB67542-7EC4-4271-809F-B12D8F7EC431 Q28475519-956BDFB5-D53B-4E35-9779-8CEED7D3FDFC Q28475879-FE5AB99B-FEA9-4D45-991D-63E77911EF15 Q28476716-E2A51CC0-F3DC-4D15-9615-5C63CB326E65 Q28478840-29424882-0152-48DA-8DB8-B910A56EEB94 Q28481006-97A8F7E3-A56E-4EE5-A871-2005A6C2A546 Q28482404-D5C8A240-C96F-4F06-879E-5B0F80C0AF1A

P2860

New use of BCG for recombinant vaccines

http://www.wikidata.org/entity/Q29615313

description

1991 nî lūn-bûn

@nan

1991 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1991 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

name

New use of BCG for recombinant vaccines

@ast

New use of BCG for recombinant vaccines

@en

type

label

New use of BCG for recombinant vaccines

@ast

New use of BCG for recombinant vaccines

@en

prefLabel

New use of BCG for recombinant vaccines

@ast

New use of BCG for recombinant vaccines

@en

P1433

Q29615313-D14E0298-9E5C-47F4-8028-9A7064895CB7

P1476

Q29615313-A5C2A869-D8A9-4265-9AB5-462413B25040

P2093

Q29615313-06829D61-ED16-469C-B271-C112D3FB48BD

Q29615313-2999436B-C65C-47FB-8B87-E5197BF98569

Q29615313-2B33DA95-F7E9-45F4-B281-80B8080DFC0D

Q29615313-3F43E23C-B46B-4190-996F-BE9CEC43ED3B

Q29615313-62285814-00FC-4F12-84EF-6ACF7D423B62

Q29615313-794EF7C7-1849-4F24-82D1-77321754953D

Q29615313-A7001AB3-8F74-4AFF-9AEE-D254300EBED9

Q29615313-F78F3A38-CE62-417B-B895-2B91B7B164C9

Q29615313-F8E43807-3A03-45D3-A48F-2D0845AABA86

Q29615313-FF09DA38-65DC-4B84-A0BA-479EF9C7EA3D

P2888

Q29615313-82010667-F340-499F-923F-8C740F78A476

P304

Q29615313-29B4C599-944E-4E47-9439-585DAD023C6A

P31

Q29615313-7350DAB7-E67A-45C4-A7C3-4BDB439ED403

P3181

Q29615313-B04B7259-2874-4243-9682-EF40375A9DF5

P356

Q29615313-A5950ECD-7802-45AC-9CAB-F4DDA4A0815E

P407

Q29615313-1A97FA56-A0AA-46C8-B8A1-E70D21E3900C

P433

Q29615313-AC97A9A4-5D5A-4A9E-A381-174B214E1F41

P478

Q29615313-F572BBAA-F771-454F-A0AF-38A22C581814

P577

Q29615313-3F107B14-638D-4FCA-B807-9655F8C1E9A1

P5875

Q29615313-7A6AFEE2-A5D0-4603-8700-AA17EDD670B1

P6179

Q29615313-F7295C8F-5166-420C-A7D6-828CDBB4FACB

P698

Q29615313-F0ECEEAF-126D-4048-8665-66CA0DAF2619

P3181

P356

P1433

P1476

New use of BCG for recombinant vaccines

@en

P2093

Bansal GP

http://www.w3.org/2001/XMLSchema#string

Bennett LT

http://www.w3.org/2001/XMLSchema#string

Benson LA

http://www.w3.org/2001/XMLSchema#string

Burlein JE

http://www.w3.org/2001/XMLSchema#string

Fuerst TR

http://www.w3.org/2001/XMLSchema#string

Hatfull GF

http://www.w3.org/2001/XMLSchema#string

Lee MH

http://www.w3.org/2001/XMLSchema#string

Stover CK

http://www.w3.org/2001/XMLSchema#string

Young JF

http://www.w3.org/2001/XMLSchema#string

de la Cruz VF

http://www.w3.org/2001/XMLSchema#string

P2888

P304

456-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

804440

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/351456A0

http://www.w3.org/2001/XMLSchema#string

P407

P433

6326

http://www.w3.org/2001/XMLSchema#string

P478

351

http://www.w3.org/2001/XMLSchema#string

P577

1991-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21250543

http://www.w3.org/2001/XMLSchema#string

P6179

1034837590

http://www.w3.org/2001/XMLSchema#string

P698

1904554

http://www.w3.org/2001/XMLSchema#string